These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 32332)
1. The effect of azapropazone on the binding of warfarin to human serum proteins [proceedings]. McElnay JC; D'Arcy PF J Pharm Pharmacol; 1978 Dec; 30 Suppl():73P. PubMed ID: 32332 [No Abstract] [Full Text] [Related]
3. Interaction between azapropazone and warfarin. Powell-Jackson PR Br Med J; 1977 May; 1(6070):1193-4. PubMed ID: 861532 [No Abstract] [Full Text] [Related]
4. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. Fehske KJ; Schläfer U; Wollert U; Müller WE Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic investigation of the interaction of azapropazone with phenytoin. Geaney DP; Carver JG; Davies CL; Aronson JK Br J Clin Pharmacol; 1983 Jun; 15(6):727-34. PubMed ID: 6871071 [TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition of xanthine oxidase by azapropazone and 8-hydroxy-azapropazone. Jahn U; Thiele K Arzneimittelforschung; 1988 Apr; 38(4):507-8. PubMed ID: 3401265 [TBL] [Abstract][Full Text] [Related]
8. Interaction between azapropazone and warfarin. McElnay JC; D'Arcy PF Br Med J; 1977 Sep; 2(6089):773-4. PubMed ID: 912313 [No Abstract] [Full Text] [Related]
9. [Use of azapropazone in dental surgery]. Perrini F; Cocchi G Dent Cadmos; 1979 Nov; 47(11):56-60. PubMed ID: 297567 [No Abstract] [Full Text] [Related]
10. Plasma protein binding of azapropazone in patients with kidney and liver disease. Jähnchen E; Blanck KJ; Breuing KH; Gilfrich HJ; Meinertz T; Trenk D Br J Clin Pharmacol; 1981 Apr; 11(4):361-7. PubMed ID: 7259929 [TBL] [Abstract][Full Text] [Related]
11. Endoscopic evaluation of the effect of azapropazone on the gastric mucosa. Hradsky M; Bruce L Scand J Rheumatol; 1978; 7(1):31-2. PubMed ID: 675173 [TBL] [Abstract][Full Text] [Related]
13. A study of the potential interactions between azapropazone and frusemide in man. Williamson PJ; Ene MD; Roberts CJ Br J Clin Pharmacol; 1984 Oct; 18(4):619-23. PubMed ID: 6487503 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory action of azapropazone. Lewis DA; Best R; Bird J J Pharm Pharmacol; 1977 Feb; 29(2):113-4. PubMed ID: 15057 [No Abstract] [Full Text] [Related]
15. The pharmacology and pharmacokinetics of azapropazone - a review. Jones CJ Curr Med Res Opin; 1976; 4(1):3-16. PubMed ID: 770078 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of azapropazone on neutrophil migration in anaesthetized swine using a multichamber blister suction technique. Mousa SA; Brown R; Chan Y; Hsieh J; Smith RD Br J Pharmacol; 1990 Feb; 99(2):233-6. PubMed ID: 2158370 [TBL] [Abstract][Full Text] [Related]
17. [Kinetics of digitoxin during antirheumatic therapy with azapropazone (author's transl)]. Faust-Tinnefeldt G; Gilfrich HJ Arzneimittelforschung; 1977; 27(10):2009-11. PubMed ID: 579114 [TBL] [Abstract][Full Text] [Related]
18. Effect of azapropazone and allopurinol on myocardial infarct size in rats. Montor SG; Thoolen MJ; Mackin WM; Timmermans PB Eur J Pharmacol; 1987 Aug; 140(2):203-7. PubMed ID: 3666017 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of rat neutrophil functional responses by azapropazone, an anti-gout drug. Mackin WM; Rakich SM; Marshall CL Biochem Pharmacol; 1986 Mar; 35(6):917-22. PubMed ID: 3006696 [TBL] [Abstract][Full Text] [Related]
20. The uricosuric action of azapropazone: dose-response and comparison with probenecid. Higgens CS; Scott JT Br J Clin Pharmacol; 1984 Sep; 18(3):439-43. PubMed ID: 6487482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]